MTOR and acute lymphoblastic leukemia: The combined inhibition of mTOR and Notch was shown to suppress T-ALL growth (89), and several pre-clinical studies suggested that mTOR modulation can effectively reverse glucocorticoid resistance in T-ALL (90–93).